文献速递肝胆胰外科围术期管理与 ERAS

肝胆闪烁显像评估ALPPS肝功能:肝脏体积高估肝功能

Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function.
PubMed 文献 · Surgery · 2017-07-18

这项多中心研究纳入60例接受ALPPS的患者,比较第一期术后肝脏体积增长与肝胆闪烁显像测得的肝功能增长。结果显示未来残肝体积中位增加78%,而肝功能仅中位增加29%,提示体积高估功能;第二期术后肝衰竭发生5/60(8%),严重并发症24/60(40%),死亡4/60(7%)。

要点

  • ALPPS第一期术后未来残肝体积中位增加78%,而肝胆闪烁显像测得的肝功能仅中位增加29%。
  • 第二期术后肝衰竭发生率为8%,严重并发症发生率为40%,死亡率为7%。
  • 体积学高估肝功能,建议采用定量肝功能检测以避免肝切除术后肝衰竭。

核心结论

  • 在ALPPS中,体积学高估了肝胆闪烁显像测得的肝功能,可能是肝衰竭高发生率的原因。
  • 强烈推荐采用定量肝功能检测以避免肝切除术后肝衰竭。

研究设计与样本

  • 多中心研究,纳入6个中心接受ALPPS并行肝胆闪烁显像的患者。
  • 肝胆闪烁显像数据在阿姆斯特丹学术医学中心按既定方案集中分析。
  • 共60例患者,其中27例有配对测量数据。

主要发现

  • 第一期术后未来残肝体积中位增加78%(四分位距48-110),中位时间8天(四分位距6-14)。
  • 27例配对测量患者中,肝胆闪烁显像测得的肝功能中位增加29%(四分位距1-55),中位时间7天(四分位距6-10)。
  • 第二期术后肝衰竭发生5/60(8%),严重并发症24/60(40%),死亡4/60(7%)。

临床怎么用

  • ALPPS术后评估肝脏再生时,不应仅依赖体积测量,应结合定量肝功能检测。
  • 肝胆闪烁显像可用于评估ALPPS第一期术后的功能性肝脏再生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) induces a rapid and extensive increase in liver volume. The functional quality of this hypertrophic response has been called into question because ALPPS is associated with a substantial incidence of liver failure and high perioperative mortality. This multicenter study aimed to evaluate functional liver regeneration in contrast to volumetric liver regeneration in ALPPS, using technetium-99m hepatobiliary scintigraphy and computed tomography volumetry, respectively. METHODS: Patients who underwent ALPPS and hepatobiliary scintigraphy in 6 centers were included. Hepatobiliary scintigraphy data were analyzed centrally at the Academic Medical Center in Amsterdam according to established protocols. Increase in liver function as measured by hepatobiliary scintigraphy after stage 1 of ALPPS was compared with the increase in liver volume. In addition, we analyzed the impact of liver function and volume on postoperative outcomes including liver failure, morbidity, and mortality. RESULTS: In 60 patients, future liver remnant volume increased by a median 78% (interquartile range 48-110) during a median 8 (interquartile range 6-14) days after stage 1, while function as measured by hepatobiliary scintigraphy increased by a median 29% (interquartile range 1-55) throughout 7 days (interquartile range 6-10) in the 27 patients with paired measurements. After stage 2 of ALPPS, liver failure occurred in 5/60 (8%) patients, severe complications in 24/60 (40%), and mortality occurred in 4/60 (7%). CONCLUSION: In ALPPS, volumetry overestimates liver function as measured by hepatobiliary scintigraphy and may be responsible for the high rate of liver failure. Quantitative liver function tests are highly recommended to avoid post hepatectomy liver failure.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Olthof PB, Tomassini F, Huespe PE, et al. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function. Surgery. 2017. PMID: 28732555. doi:10.1016/j.surg.2017.05.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。